JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 590,800 shares, a decrease of 6.0% from the March 15th total of 628,800 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

JCR Pharmaceuticals Price Performance

Shares of JCR Pharmaceuticals stock opened at $5.22 on Wednesday. JCR Pharmaceuticals has a fifty-two week low of $5.22 and a fifty-two week high of $6.20. The firm has a fifty day moving average price of $6.48 and a two-hundred day moving average price of $8.16.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.